Compare CYRX & MCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYRX | MCI |
|---|---|---|
| Founded | 1999 | 1971 |
| Country | United States | United States |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.3M | 362.0M |
| IPO Year | 2008 | N/A |
| Metric | CYRX | MCI |
|---|---|---|
| Price | $10.20 | $17.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $12.94 | N/A |
| AVG Volume (30 Days) | ★ 404.5K | 57.3K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.46% |
| EPS Growth | ★ 156.22 | N/A |
| EPS | 1.40 | ★ 1.82 |
| Revenue | ★ $176,177,000.00 | N/A |
| Revenue This Year | $11.06 | N/A |
| Revenue Next Year | $8.45 | N/A |
| P/E Ratio | ★ $7.11 | $9.81 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.21 | $17.24 |
| 52 Week High | $11.45 | $23.00 |
| Indicator | CYRX | MCI |
|---|---|---|
| Relative Strength Index (RSI) | 72.50 | 38.38 |
| Support Level | $9.18 | $17.24 |
| Resistance Level | $10.23 | $18.19 |
| Average True Range (ATR) | 0.42 | 0.58 |
| MACD | 0.19 | 0.05 |
| Stochastic Oscillator | 94.75 | 31.28 |
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.